Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2015 16:01 ET | Source: Emergent Biosolutions, Inc.

FDA Approves Emergent BioSolutions' BioThrax for Post-Exposure Prophylaxis

GAITHERSBURG, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) approved its supplemental Biologics...
November 05, 2015 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Third Quarter and Nine Months 2015 Financial Results

GAITHERSBURG, Md., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2015. FINANCIAL...
October 22, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Third Quarter 2015 Financial Results and Conduct a Conference Call on November 5, 2015

GAITHERSBURG, Md., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, November 5, 2015 at 5:00 pm (Eastern Time) to discuss the...
August 13, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program

GAITHERSBURG, Md., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Centers for Disease Control and Prevention (CDC) has exercised options under...
August 06, 2015 07:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a Separate Publicly-Traded Company

GAITHERSBURG, Md., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that its Board of Directors has authorized management to pursue a tax-free spin-off of the...
August 06, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Second Quarter and Six Months 2015 Financial Results and Reaffirms 2015 Guidance

GAITHERSBURG, Md., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and six months ended June 30, 2015. Financial highlights...
August 03, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Expands Biodefense Business Through Launch of a Military-Grade Auto-Injector Device for Chemical Threats

GAITHERSBURG, Md., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it is launching a ruggedized, military-grade auto-injector device, known as...
July 23, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Second Quarter 2015 Financial Results and Conduct a Conference Call on August 6, 2015

GAITHERSBURG, Md., July 23, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, August 6, 2015 at 8:00 am (Eastern Time) to discuss the financial...
July 20, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Awarded $19.7 Million BARDA Contract to Develop and Manufacture Ebola Monoclonal Antibodies

GAITHERSBURG, Md., July 20, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority...
May 19, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Signs Long-Term Manufacturing Agreement With Prometic Life Sciences

GAITHERSBURG, Md., May 19, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a strategic long-term manufacturing agreement with ProMetic Life Sciences...